Xenon Pharmaceuticals Inc. (XENE)

NASDAQ: XENE · Real-Time Price · USD

41.66

+0.18 (0.43%)

At close: Feb 17, 2026, 4:00 PM EST

41.50

-0.16 (-0.38%)

After-hours: Feb 17, 2026, 5:50 PM EST

Xenon Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 17, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	3,219	2,989	3,503	2,466	1,643	554
Market Cap Growth	4.34%	-14.68%	42.03%	50.06%	196.62%	57.13%
Enterprise Value	2,672	2,195	2,875	1,721	1,397	364
Last Close Price	41.66	39.20	46.06	39.43	31.24	15.38
PS Ratio	429.24	-	-	261.41	89.14	17.22
PB Ratio	5.74	3.96	3.78	3.42	2.99	3.23
P/TBV Ratio	5.75	3.96	3.78	3.42	2.99	3.23
PEG Ratio	-	2.51	2.51	2.51	2.51	2.51
EV/Sales Ratio	356.31	-	-	182.44	75.77	11.31
Debt / Equity Ratio	0.02	0.01	0.01	0.01	0.02	0.02
Net Debt / Equity Ratio	-0.98	-0.99	-0.99	-0.98	-0.99	-1.01
Net Debt / EBITDA Ratio	1.62	2.69	4.34	5.56	6.96	5.67
Net Debt / FCF Ratio	2.16	4.04	5.87	6.84	7.60	3.42
Asset Turnover	0.01	-	-	0.01	0.05	0.19
Quick Ratio	12.08	17.66	23.43	26.12	38.72	12.10
Current Ratio	12.53	17.85	23.65	26.44	39.03	12.30
Return on Equity (ROE)	-45.14%	-27.85%	-22.12%	-19.72%	-21.87%	-21.90%
Return on Assets (ROA)	-29.50%	-19.80%	-15.57%	-12.17%	-12.97%	-11.61%
Return on Capital Employed (ROCE)	-59.80%	-36.60%	-22.80%	-17.70%	-14.20%	-17.90%
Earnings Yield	-9.52%	-7.84%	-5.21%	-5.08%	-4.80%	-5.21%
FCF Yield	-7.87%	-6.17%	-4.47%	-4.21%	-4.35%	-9.16%
Buyback Yield / Dilution	-4.00%	-16.45%	-10.48%	-38.77%	-21.09%	-23.57%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q